Virta Health raises $45 million in investment to expand low-carb treatment of type 2 diabetes

Virta Health has just raised another $45 million in investment, after a highly successful one-year keto trial showing that type 2 diabetes can be reversed. The series B raise increases their total funding to more than $75 million.

This is taking the company another step closer to their ambitious mission: reversing type 2 diabetes in 100 million people by 2025. It also shows that some very smart people in Silicon Valley – the investors include Venrock, Obvious Ventures and Founders Fund – believe in the promise of a ketogenic diet to revolutionize the treatment of type 2 diabetes.

• Virta Health: Virta Health Raises $45 Million to Expand Treatment for Type 2 Diabetes Reversal
• Virta Health: With $45 million of new capital, Virta is ready to accelerate its growth